Clinical Trials Directory

Trials / Completed

CompletedNCT03553992

An Extended Facebook Intervention for Young Sexual and Gender Minority Smokers

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
173 (actual)
Sponsor
University of California, San Francisco · Academic / Other
Sex
All
Age
18 Years – 25 Years
Healthy volunteers
Accepted

Summary

The 2-year research plan will test the Extended Put It Out Project (POP-6) in a pilot randomized trial (N=168) compared to TSP-6, as well as comparing POP-6 and TSP-6 to the POP-3 and TSP-3 interventions from a previously-conducted trial. Participants will be young adults who smoke, identify as sexual or gender minorities (SGM), and use Facebook. Primary outcome will be biochemically verified 7-day abstinence from smoking at 3 and 6 months. Secondary outcomes will be a quit attempt (y/n), stage of change, and thoughts about tobacco abstinence at 3 and 6 months.

Detailed description

Participants will be randomized to one of two conditions: (1) a 6-month Facebook-delivered intervention addressing tobacco use, tailored to SGM young adults; or (2) a 6-month Facebook intervention targeting tobacco use. Both interventions will include 180 days of Facebook-based messages and activities tailored to participants' readiness to quit smoking. Assessments will occur at baseline, 3, and 6 months follow-up. Assessments will include measures on smoking, thoughts about abstinence, and SGM identity experiences. All participants who report no past 7-day smoking will be asked to give biochemical verification of smoking status with saliva nicotine test kits that will be mailed to participants.

Conditions

Interventions

TypeNameDescription
BEHAVIORALPOP-6:90 days of Facebook messaging, weekly live sessions targeting tobacco use and tailored to SGM young adults Drug: nicotine patch 14-day supply of nicotine patch
BEHAVIORALTSP-6:90 days of Facebook messaging, weekly live sessions targeting tobacco use Drug: nicotine patch 14-day supply of nicotine patch

Timeline

Start date
2018-10-29
Primary completion
2019-07-07
Completion
2019-07-07
First posted
2018-06-12
Last updated
2020-10-19

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03553992. Inclusion in this directory is not an endorsement.